Life Sciences Times

NeoGenomics Reports Higher Second-Quarter Revenue, Raises 2026 Outlook

Synlogic, Caldera Therapeutics Agree to Merge in All-Stock Deal

Qlaris Bio Appoints Parisa Zamiri to Board of Directors

Landmark Bio, Syngoi Technologies Rebrand as Artis BioSolutions

CORE Biomedicine Raises $21 Million to Advance Precision Cancer Therapies

Epredia Adds Automated Pathology Sample Archiving Systems to U.S. Portfolio

Aqtual Names Daniil Kalyuzhny Chief Financial Officer

Included Health to Acquire Firefly Health in Clinically Integrated Health Plan Deal

Newleos Names Former 89bio CEO Rohan Palekar as Board Chairman

Enveric Says Final FDA Psychedelic Drug Guidance Supports EB-003 Development Strategy